Dr Ganesan Venkatasubramanian is an Indian psychiatrist and clinician-scientist who works as a professor of psychiatry at NIMHANS (National Institute of Mental Health and Neurosciences), Bangalore. He is known for his studies in the fields of schizophrenia, transcranial, brain imaging, neuroimmunology, neurometabolism and several other areas of biological psychiatry. G Venkatasubramanian was awarded with one of the highest Indian science awards, the Shanti Swarup Bhatnagar Prize for Science and Technology, for his contributions to medical sciences in 2018.

Jayendra Shinde is a Co-Founder and CEO at Crosscope in California. Their company mainly focuses on development of pathologist-centric next generation artificial intelligence tools, such as ORION AI and SCOPE H&E AI. These tools are transforming digital pathology with ability to make more informed, accurate and faster decisions. Their compony, Crosscope has been awarded with Indian Achiever’s Award 2021-2022 as a “Best Promising Start-Up” under the healthcare category for developing next-generation digital pathology with the ability to improve cancer care and patient outcome with the power of AI.

Dr. Malay Patra, assistance professor in Department of Chemical Sciences, Tata Institute of Fundamental Research, is a young and an enthusiastic researcher. In his postdoctoral study he worked on radiopharmaceuticals and areas of ‘Platinum Anticancer Drugs’ and ‘Cell Biology’. He developed novel radioactive immuno-PET tracers for detection of prostate cancer. He is currently working on synthesis and characterization of molecules / materials for biological or medicinal applications. The main objective of their research is to address the healthcare needs of our society.

Dr Shashank Tripathi, Assistant Professor in Microbiology & Cell Biology Department, Centre for Infectious Disease Research, Indian Institute of Science. His group is working on understanding virus-host interactions of emerging human RNA viruses including Influenza, SARS-CoV-2, and Flaviviruses and to further translate this knowledge for the development of broad-spectrum antivirals and vaccines. He was awarded Wellcome Trust India Alliance Intermediate fellowship in 2018.

Dr. Rahul Purwar, current associate professor at IIT-B and founder of ImmunoACT, is a pioneering scientist in the field of tumour immunology and CAR-T cell therapy. In 2018, he founded ImmunoACT and is currently driving the clinical trials towards CAR-T cellimmunotherapy for cancer patients in collaboration with Tata Memorial Hospital.